All the economic studies of genomic tests for breast cancer rely on modeling rather than randomized controlled trials or other direct trial data.
Robert D. Lieberthal, PhD
Advertisement
Articles by Robert D. Lieberthal, PhD
Advertisement
Latest Updated Articles
- Economics of Genomic Testing for Women With Breast Cancer
December 23rd 2013
Advertisement
Advertisement
Trending on AJMC
1
AI Chatbots Score Below 28% on Colorectal Cancer Questions
2
5 Notable FDA Approvals From the First Half of 2026
3
FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma
4
Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues
5